IMPACT OF COADMINISTRATION WITHOUT OR WITH FOOD ON THE 96-WEEK EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE (TAF) IN VIRALLY SUPPRESSED CHRONIC HBV PATIENTS SWITCHED FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TAF

被引：0

作者：

Kao, Jia-Horng ^{[1
]}

Chuang, Wan-Long ^{[2
]}

Chen, Chi-Yi ^{[3
]}

Ahn, Sang Hoon ^{[4
]}

Fung, Scott K. ^{[5
]}

Elkhashab, Magdy ^{[6
]}

Hann, Hie-Won L. ^{[7
]}

Ravendhran, Natarajan ^{[8
]}

Nguyen, Tuan T. ^{[9
]}

Tan, Susanna ^{[10
]}

Flaherty, John F. ^{[10
]}

Gagger, Anuj ^{[10
]}

Gao, Bing ^{[10
]}

Brainard, Diana M. ^{[10
]}

Phan, Charles G. ^{[11
]}

Lim, Young-Suk ^{[12
]}

Ferret, Maria Asuncion Buti ^{[13
]}

Lampertico, Pietro ^{[14
]}

机构：

[1] Natl Taiwan Univ Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan

[2] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan

[3] Chia Yi Christian Hosp, Dept Internal Med, Chiayi, Taiwan

[4] Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea

[5] Univ Toronto, Toronto, ON, Canada

[6] Toronto Liver Ctr, Res, Toronto, ON, Canada

[7] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA

[8] Digest Dis Associates PA, Wyomissing, PA USA

[9] T Nguyen Res & Educ Inc, San Diego, CA USA

[10] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

[11] Mem Hermann Sugar Land, Sugar Land, TX USA

[12] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol,Liver Ctr, Seoul, South Korea

[13] Hosp Univ Vall dHebron, Dept Internal Med, Liver Unit, Barcelona, Spain

[14] Fdn Irccs Ca Granda Osped Maggiore Policlin, CRC AM & A Migliavacca Ctr Liver Dis, Div Gastroenterol & Hepatol, Milan, Italy

来源：

HEPATOLOGY | 2020年 / 72卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

795

引用

页码：484A / 484A

页数：1

共 50 条

[21] A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): final week 96 efficacy and safety results
Lampertico, Pietro
Buti, Maria
Ramji, Alnoor
Fung, Scott
Ahn, Sang Hoon
Chuang, Wan-Long
Yoon, Seung Kew
Kao, Jia-Horng
Chen, Chi-Yi
Tam, Edward
Khalili, Mandana
Bae, Ho
Ma, Xiaoli
Tak, Won Young
Flaherty, John F.
Gaggar, Anuj
Suri, Vithika
Tan, Susanna
Liu, Yang
Wu, George
Subramanian, Mani
Hann, Hie-Won
Agarwal, Kosh
Lim, Young-Suk
Chan, Henry
JOURNAL OF HEPATOLOGY, 2020, 73 : S67 - S68
[22] BONE AND RENAL SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 8 YEARS IN CHRONIC HBV ( CHB) PATIENTS WITH UNDERLYING RISK FACTORS FOR USE OF TENOFOVIR DISOPROXIL FUMARATE ( TDF)
Buti, Maria
Gane, Edward J.
Agarwal, Kosh
Wong, Grace Lai-Hung C.
Lim, Young-Suk
Chen, Chi-Yi
Lim, Seng Gee
Yatsuhashi, Hiroshi
Fung, Scott K.
Abramov, Frida
Wang, Hongyuan
Yee, Leland J.
Flaherty, John F.
Pan, Calvin Q.
Marcellin, Patrick
HEPATOLOGY, 2023, 78 : S507 - S509
[23] WEEK 96 EFFICACY AND SAFETY RESULTS OF TENOFOVIR ALAFENAMIDE (TAF) COMPARING TO TENOFOVIR DISOPROXIL FUMARATE (TDF) IN CHRONIC HEPATITIS B (CHB), HBEAG-POSITIVE PATIENTS: A GLOBAL PHASE 3 STUDY
Agarwal, Kosh
Fung, Scott
Seto, Wai-Kay
Lim, Young-Suk
Gane, Edward
Janssen, Harry L.
Chuang, Wan-Long
Bae, Ho
Yoon, Ki Tae
Flaherty, John F.
Lau, Audrey
Gaggar, Anuj
Suri, Vithika
Cathcart, Andrea
Lin, Lanjia
Chan, Alain
Shalimar, Mani Subramanian
Furusyo, Norihiro
Buti, Maria
Chan, Henry L.
GASTROENTEROLOGY, 2017, 152 (05) : S1085 - S1086
[24] A PHASE 3 STUDY COMPARING SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TENOFOVIR ALAFENAMIDE (TAF) WITH CONTINUED TDF TREATMENT IN VIROLOGICALLY-SUPPRESSED PATIENTS WITH CHRONIC HEPATITIS B (CHB): WEEK 48 EFFICACY AND SAFETY RESULTS
Chan, Henry Lik Yuen
Lampertico, Pietro
Buti, Maria
Fung, Scott
Ahn, Sang Hoon
Chuang, Wan-Long
Tak, Won Young
Ramji, Alnoor
Chen, Chi-Yi
Tam, Edward
Bae, Ho
Ma, Xiaoli
Flaherty, John
Gaggar, Anuj
Lau, Audrey
Feierbach, Becket
Wu, George
Suri, Vithika
Subramanian, Mani
Huy Trinh
Yoon, Seung-Kew
Agarwal, Kosh
Lim, Young-Suk
GUT, 2019, 68 : A142 - A143
[25] IMPACT OF TREATMENT WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) ON HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)
Chan, Henry Lik Yuen
Lim, Young-Suk
Seto, Wai Kay
Ning, Qin
Agarwal, Kosh
Janssen, Harry L. A.
Pan, Calvin O.
Chuang, Wan Long
Izumi, Namiki
Fung, Scott
Shalimar
Brunetto, Maurizia
Flaherty, John
Mo, Shuyuan
Cheng, Cong
Lin, Lanjia
Gaggar, Anuj
Subramanian, Mani
Marcellin, Patrick
Gane, Edward
Hou, Jinlin
Buti, Maria
GUT, 2020, 69 : A75 - A76
[26] Tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) switches: real-world observation of impact on lipid profiles
Banks, T.
Ashton, K.
Ustianowski, A.
Uriel, A.
HIV MEDICINE, 2020, 21 : 56 - 57
[27] CHRONIC HBV PATIENTS WHO SWITCHED TO TENOFOVIR ALAFENAMIDE (TAF) AFTER EITHER 2 OR 3 YEARS OF PRIOR TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT DEMONSTRATED IMPROVEMENT IN BONE AND RENAL SAFETY
Buti, Maria
Izumi, Namiki
Lim, Young-Suk
Janssen, Harry L.
Kao, Jia-Horng
Streinu-Cercel, Adrian
Nurmukhametova, Elena
Ma, Xiaoli
Tabak, Omer
Jablkowski, Maciej
Suri, Vithika
Flaherty, John F.
Lau, Audrey H.
Gaggar, Anuj
Mo, Shuyuan
Chowdhury, Abhijit
Fung, Scott
Chuang, Wan-Long
Gane, Edward
GASTROENTEROLOGY, 2019, 156 (06) : S1195 - S1196
[28] IMPACT OF TREATMENT WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) ON HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)
Lim, Young-Suk
Chan, Henry Lik Yuen
Seto, Wai-Kay
Ning, Qing
Agarwal, Kosh
Janssen, Harry L. A.
Pan, Calvin Q.
Chuang, Wan Long
Izumi, Namiki
Fung, Scott K.
Shalimar
Brunetto, Maurizia R.
Flaherty, John F.
Mo, Shuyuan
Cheng, Cong
Lin, Lanjia
Gaggar, Anuj
Subramanian, Mani
Marcellin, Patrick
Gane, Edward J.
Hou, Jinlin
Buti, Maria
HEPATOLOGY, 2019, 70 : 126A - 127A
[29] FACTORS ASSOCIATED WITH A LACK OF VIRAL SUPPRESSION IN CHRONIC HBV ( CHB) PATIENTS AFTER 8 YEARS OF TREATMENT WITH TENOFOVIR ALAFENAMIDE ( TAF) OR TENOFOVIR DISOPROXIL FUMARATE ( TDF) FOLLOWED BY TAF TREATMENT
Gane, Edward J.
Buti, Maria
Fung, Scott K.
Chan, Henry Lik Yuen
Izumi, Namiki
Chuang, Wan Long
Ahn, Sang Hoon
Mehta, Rajiv M.
Gurel, Selim
Abramov, Frida
Yee, Leland J.
Wang, Hongyuan
Mateo, Roberto
Flaherty, John F.
Ma, Xiaoli
Pan, Calvin Q.
Lim, Young-Suk
Marcellin, Patrick
HEPATOLOGY, 2023, 78 : S519 - S520
[30] EFFICACY AND SAFETY RESULTS 48 WEEKS AFTER SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TENOFOVIR ALAFENAMIDE (TAF) VS CONTINUED TDF TREATMENT IN VIROLOGICALLY-SUPPRESSED PATIENTS WITH CHRONIC HEPATITIS B (CHB)
Lampertico, Pietro
Buti, Maria
Fung, Scott
Ahn, Sang Hoon
Chuang, Wan-Long
Tak, Won Young
Ramji, Alnoor
Chen, Chi-Yi
Tam, Edward
Bae, Ho
Ma, Xiaoli
Flaherty, John F.
Gaggar, Anuj
Lau, Audrey H.
Feierbach, Becket
Wu, George
Suri, Vithika
Subramanian, Mani
Trinh, Huy N.
Yoon, Seung-Kew
Agarwal, Kosh
Lim, Young-Suk
Chan, Henry L.
GASTROENTEROLOGY, 2019, 156 (06) : S1195 - S1195

← 1 2 3 4 5 →